Alteraciones metabólicas y síndrome de redistribución grasa relacionados con el tratamiento de la infección por el virus de la inmunodeficiencia humana

Castro Sansores, Carlos J.
Med. interna Méx ; 17(6): 282-288, nov.-dic. 2001. tab
Artículo en Español | LILACS | ID: lil-314334

Documentos relacionados

  1. PCSK9 and ANGPTL3 levels correlate with hyperlipidemia in HIV-lipoatrophy, are regulated by fasting and are not affected by leptin administered in physiologic or pharmacologic doses.
  2. [Gegen Qinlian Decoction formula syndrome and its application in diabetes, hypertension, hyperlipidemia and obesity].
  3. ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis.
  4. A novel fully human anti-NT-ANGPTL3 antibody from phage display library exhibits potent ApoB, TG, and LDL-C lowering activities in hyperlipidemia mice.
  5. SHORT Syndrome: Systematic Appraisal of the Medical and Dental Phenotype.
  6. The Clinical Characteristics and Potential Molecular Mechanism of LMNA Mutation-Related Lipodystrophy.
  7. Ultra-Rare Disorder in a Young Girl with Lipodystrophy: Analbuminemia.
  8. Untargeted and Targeted Metabolomics Reveal the Active Peptide of <i>Eupolyphaga sinensis</i> Walker against Hyperlipidemia by Modulating Imbalance in Amino Acid Metabolism.
  9. Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients.
  10. Insight into structural characteristics of theabrownin from Pingwu Fuzhuan brick tea and its hypolipidemic activity based on the in vivo zebrafish and in vitro lipid digestion and absorption models.